Sorafenib Sensitizes Glioma Cells to the BH3 Mimetic ABT-737 by Targeting MCL1 in a STAT3-Dependent Manner

Journal

  • Neoplasia

    Neoplasia 17 (7), 564-573, 2015-07

    Elsevier BV

Citations (1)*help

See more

Keywords

Report a problem

Back to top